Your Life your connection to The Boston Globe
White Coat Notes: News from the Boston-area medical community
Send your comments and tips to

Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Scott Allen
Alice Dembner
Carey Goldberg
Liz Kowalczyk
Stephen Smith
Colin Nickerson
Beth Daley
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
 Short White Coat blogger Ishani Ganguli
Week of: May 20
Week of: May 13
Week of: May 6
Week of: April 29
Week of: April 22
Week of: April 15

« Children of long-lived parents have fewer heart risks | Main | Have you looked under your hood? »

Tuesday, March 13, 2007

Today's Globe: Carbon confusion, DMR name, Army surgeon general, beta carotene, obesity surgery link, stent maker's other side, drug firm buy

The fast-growing world of voluntary carbon offsets an unregulated, largely online marketplace has skyrocketed worldwide. Although specialists say some of the money is well spent, it can be difficult for consumers to figure out if they are buying any new environmental benefit.

The name of the state Department of Mental Retardation is an offensive relic that should be abandoned, some lawmakers say. Senators Karen E. Spilka and Stephen Brewer are sponsoring a bill that calls for the department to find a politically correct name.

Lieutenant General Kevin C. Kiley, the Army's surgeon general, agreed to step down from his position after weeks of intense public criticism stemming from revelations about poor conditions at Walter Reed Army Medical Center, defense officials said yesterday.

Carrots, rich in beta carotene, have long been thought to sharpen eyesight, but beta carotene pills are powerless against a common type of vision loss among older people, according to a new study by Dr. William G. Christen of Brigham and Women's Hospital and others.

Some obese people who have weight-loss surgery, particularly younger women, develop a neurologic condition most often seen in severe alcoholics and linked to a vitamin deficiency, researchers from Wake Forest University School of Medicine said yesterday.

Plagued by chronic bad news about its marquee cardiovascular products, stent maker Boston Scientific Corp. yesterday moved to shift Wall Street's focus to a strong, solidly growing part of its business: endoscopy products used in treating everything from kidney stones to throat and digestive-tract cancers.

Schering-Plough Corp. agreed to buy Akzo Nobel NV's drug-making division Organon for $14.4 billion to gain the world's third-largest maker of birth-control pills and a stable of experimental medicines.

Posted by Elizabeth Cooney at 06:26 AM
Sponsored Links